- Home
- LGVN vs NXPL Comparison
LGVN vs NXPL Comparison
Compare LGVN & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- NXPL
- Stock Information
- Founded
- LGVN 2014
- NXPL 1997
- Country
- LGVN United States
- NXPL United States
- Employees
- LGVN N/A
- NXPL N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- NXPL Telecommunications Equipment
- Sector
- LGVN Health Care
- NXPL Telecommunications
- Exchange
- LGVN Nasdaq
- NXPL Nasdaq
- Market Cap
- LGVN 16.4M
- NXPL 17.9M
- IPO Year
- LGVN 2021
- NXPL N/A
- Fundamental
- Price
- LGVN $0.77
- NXPL $0.80
- Analyst Decision
- LGVN Strong Buy
- NXPL
- Analyst Count
- LGVN 2
- NXPL 0
- Target Price
- LGVN $6.50
- NXPL N/A
- AVG Volume (30 Days)
- LGVN 410.9K
- NXPL 132.4K
- Earning Date
- LGVN 11-11-2025
- NXPL 11-13-2025
- Dividend Yield
- LGVN N/A
- NXPL N/A
- EPS Growth
- LGVN N/A
- NXPL N/A
- EPS
- LGVN N/A
- NXPL N/A
- Revenue
- LGVN $2,073,000.00
- NXPL $58,766,000.00
- Revenue This Year
- LGVN N/A
- NXPL N/A
- Revenue Next Year
- LGVN N/A
- NXPL N/A
- P/E Ratio
- LGVN N/A
- NXPL N/A
- Revenue Growth
- LGVN 68.67
- NXPL N/A
- 52 Week Low
- LGVN $0.63
- NXPL $0.43
- 52 Week High
- LGVN $2.48
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- LGVN 38.17
- NXPL 56.74
- Support Level
- LGVN $0.74
- NXPL $0.69
- Resistance Level
- LGVN $0.85
- NXPL $0.74
- Average True Range (ATR)
- LGVN 0.05
- NXPL 0.06
- MACD
- LGVN 0.02
- NXPL 0.01
- Stochastic Oscillator
- LGVN 34.25
- NXPL 45.17
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.